Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-01-31 00:00:00 ET · period of report 2023-01-30 · accession 0001209191-23-005717 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-31 | 2023-01-30 | VRTX | CARNEY LLOYD | Dir | S - Sale | $320.52 | -2,700 | 5,474 | -33% | -$865.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-30 | S | D | 324 | $321.84 | 4,150 | D | — | — | (F2) Mr. Carney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $321.84 (range $321.54 to $322.23). |
| 2 | Common | Common Stock | 2023-01-30 | S | D | 1,000 | $320.70 | 4,474 | D | — | — | (F2) Mr. Carney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $320.70 (range $320.43 to $321.31). |
| 3 | Common | Common Stock | 2023-01-30 | S | D | 1,376 | $320.08 | 5,474 | D | — | — | (F2) Mr. Carney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $320.08 (range $319.40 to $320.38). |